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Abstract 
In this study we assessed microglia morphology in male, pre-menopausal female, and post-
menopausal female mice (Male n = 5-6; Pre M n = 6; PM n = 8) following 8 hours of 
reperfusion, as a measurable response to injury. We hypothesized that because the size of infarct 
is decreased in pre-menopause female versus post-menopause female and male mice, that 
changes in microglia morphology post stroke will vary according to sex group. Using skeletal 
and fractal analysis, we found that ramified morphology is decreased in proximity to injury 
(endpoints/cell region main effect: F (3,68) = 20.71, p < 0.0001; process length/cell region main 
effect: F (3,68) = 11.63, p < 0.0001); however there are no differences among sex groups for the 
endpoints/cell variable (F (2,68) = 0.6, p < 0.55). In addition, fractal dimension decreased in 
proximity to the ischemic region with significant differences according to sex group (two-way 
ANOVA: region: F (3,57) = 36.80, p < 0.0001; sex group: F (2,19) = 7.5, p < 0.01). The focus of this 
study is on the basic discovery of microglia morphological response that can be used to develop 
treatments that have minimal variability among sex groups. 
  
 Chapter 1 
Introduction 
 Strokes are the leading cause of disability in the United States and are a significant health 
concern that affects over 33 million people worldwide (CDC, 2018). Given that females account 
for more than half of all stroke deaths and have a greater lifetime risk for stroke, identifying the 
pathophysiology behind the sex-specific difference in immune cells may help identify 
interventions to improve outcomes. This thesis researches sex differences in microglia 
morphology as a measurable response to ischemic stroke and reperfusion. The initial chapters 
will discuss stroke etiology, the pathophysiology of ischemic stroke to include the brain cell 
types involved in post-stroke injury and repair with a focus on the role of microglia in the surveil 
of the parenchyma with ischemia, infarction, and dysfunction. The remaining chapters are 
devoted to the methodologies and results formed in this research, concluded by the clinical 
significance these findings play in understanding the role of sex in pathology and disease 
outcomes.  
Types of Stroke  
 A stroke is the occlusion or eruption of a blood vessel in the brain that through a cascade 
of events leads to neuronal tissue ischemia and necrosis. As of 2016, strokes became the fifth 
leading cause of death in the United States (Mozzafarian et al., 2016). As a leading cause of 
death and occurring nearly every 40 seconds, strokes are a costly incidence, accounting for $34 
billion each year in health care services, medications, and treatments (Mozzafarian et al., 2016). 
By understanding the pathophysiology of immune cells such as microglia and the role played in 
mitigating ischemic injury, personalized evidenced-based nursing interventions can improve 
healing and reduce the overall death, cost, incidence, and recurrence rates.  
 Hemorrhagic strokes. A hemorrhagic stroke occurs from the rupture of a weakened 
blood vessel that causes primary damage through ischemia of the parenchymal and secondary 
damage from increased intracranial pressure, cytotoxicity, oxidative stress and excitotoxicity 
(Shi, 2017). The main causes of a hemorrhagic stroke are cerebral aneurysms and arteriovenous 
malformations. A cerebral aneurysm develops at the bifurcation of arteries and is created from 
constant pressure changes that weaken the walls resulting in a ballooning of the vessel. An 
arteriovenous malformation (AVM) is the weakening of the area that connects arteries and veins 
together. As the wall weakens over time, microbleeds can occur and with a rapid change in 
pressure can lead to a hemorrhage. The primary result of bleeding produces a physical disruption 
of the cerebral architecture, while secondary cascades result in the deterioration of patients with 
a hemorrhage (Shi, 2017). As a result, inflammation, oxidative stress, and blood-brain barrier 
dysfunction lead to neuronal tissue injury.   
 Transient ischemic attack. A transient ischemic attack, or TIA, is a temporary blockage 
in blood flow to the brain, sometimes referred to a “mini-stroke”, despite being capable of 
causing true stroke-like ischemia. A TIA can result from a mired of complications and are 
categorized by embolic, lacunar, and large artery/low flow TIA. An embolic TIA is a single but 
prolonged episode of focal ischemia caused by a clot that has broken off from its original 
location and has traveled to an artery in the brain. A lacunar or small penetrating vessel TIA is 
caused by the stenosis of an intracerebral penetrating vessel that stems from the middle cerebral 
artery, basilar artery, vertebral artery, or Circle of Willis, while a large artery/low flow TIA is an 
atherosclerotic abrasion at the internal carotid (Hadjiev &Mineva, 2007). Though these attacks 
are classified by a symptom duration of less than an hour and do not show evidence of acute 
infarction, focal neurological damage can occur. Infarction does not occur because, during local 
brain hypoperfusion, ion gradients are not irreversibly damaged, therefore decreasing the 
formation of the ischemic penumbra (Hadjiev &Mineva, 2007). It is from this that the benefits of 
neuroprotection and reperfusion are more obvious in TIA compared to more damaging forms of 
stroke.   
 Ischemic stroke. An ischemic stroke is a neuronal death caused by oxygen deprivation 
that ultimately leads to tissue infarction and focal brain injury. With ischemic strokes accounting 
for 87% of all strokes, it has become a major cause of mortality and disability across the globe 
(Mozzafarian et al., 2016). Though declining since 2010, the mortality rate of stroke continues to 
be a significant problem despite attention to modifiable risk factors such as smoking and 
hypertension because, among many reasons, of a lack of understanding and treatment based on 
sex differences (Morrison & Filosa, 2016).  It is known that stroke is less prevalent in women 
until menopause when the incidence and injury surpass the incidence rate for men. In addition, 
the mortality rate for post-menopausal women with ischemic stroke is greatly increased and 
approximates 60% of all stroke deaths (Samai & Martin-Schild, 2015) 
In general, cerebral ischemia in the brain can occur from acute events such as cardiac 
arrest, drowning, strangulation, choking, traumatic brain injuries (TBI), and carbon monoxide 
poisoning, or more chronic causes such as large artery atherosclerosis, cardioembolism, and 
small artery occlusions (Alexander, 2013). Depending on the subclassification of ischemic 
stroke, these events produce ischemia via thrombi, emboli, and/or hypercoagulability.  
Thrombotic ischemic stroke. A thrombotic ischemic stroke occurs from arterial stenosis 
or the occlusion of vessels within the brain. Luminal changes caused by plaque accumulation 
within the main large arteries in the cerebral circulation (i.e. carotid artery, middle cerebral 
artery, anterior cerebral artery, posterior cerebral artery, vertebral artery, or basilar artery) or 
small arterial occlusions of cerebral vessels are considered thrombotic (Alexander, 2013). 
Similar to coronary artery disease and peripheral vascular disease, large artery atherosclerosis of 
cerebral vessels results from the progressive accumulation of plaque within the vessel wall 
reducing the interior diameter of the lumen. The risk factors mentioned above in general cause 
increased vascular resistance. In addition to resistance, systemic and local factors such as 
increased platelet reactivity and tissue factors contribute to the formation of thrombi in 
vulnerable plaques which can become lodged in the lumen and impede flow (Alexander, 2013).  
Embolic ischemic stroke. An embolic stroke occurs when a blood clot originating 
elsewhere in the body (artery-to-artery and cardiac embolism) dislodges and then enters the 
cerebral circulation. When the clot size exceeds the vessel diameter, an occlusion will occur and 
result in ischemia to the area supplied by the occluded artery.  An artery-to-artery embolism is 
more likely to form from the develop from large artery atherosclerotic plaque, decreased forward 
flow, and the presence of luminal abnormalities (Deb, Sharma, & Hassan, 2010). When a portion 
of the plaque, clot, or thrombus becomes dislodged and travel to into the cerebral circulation to 
initiate an embolic stroke. A cardio-embolism is responsible for approximately 20% of all 
ischemic strokes and form from cardiac abnormalities such as atrial fibrillation, mechanical 
prosthetic valves, and valvular heart disease are associated with embolus formation that can lead 
to cerebral embolism and ischemic stroke (Furie et al., 2011). When an embolus originates in the 
heart, it can travel through the cardiac cycle and then be ejected from the left ventricle. The 
embolus then enters the cerebral circulation via the carotid arteries that originate in the aortic 
arch or into the vertebral arteries via the subclavian arteries.  
Hypercoagulability/Thrombophilia. In ischemic strokes, thrombophilia, or the tendency 
to clot may result if there are hematologic clotting abnormalities that predispose an individual to 
premature clotting. Primary thrombophilic states are thought to be responsible for 1–4% of all 
ischemic strokes (Furie et al., 2011). Prothrombin gene mutations found in patients with 
cryptogenic stroke and Patent Foramen Ovale (PFO), for example, may be associated with 
venous thromboembolism. This can result in ischemic stroke when a thrombus from the venous 
circulation shunts to the left side of the heart, becoming an arterial thrombus that travels to the 
brain.   
Brain Cells Involved in Ischemic Stroke 
 Among immune-to-brain interactions, it is now recognized that there is a dynamic 
interaction between the central nervous system and the immune system that extends from 
pathology to homeostasis. With the immune system acting as a sensor of environment, different 
responses in tissue can be seen through microglial activation (Jakel & Dimou, 2017). However, 
before understanding the complex relationship between the two during an ischemic event, it is 
important to discuss the function of resident cells within the brain.  
 Neurons. Neurons are the information messengers of the central nervous systems. Using 
electrical impulses, signals can be transmitted from one area of the brain to the surrounding 
structures and components of the nervous system. The three types of neurons area sensory, 
motor, and interneurons. Sensory neurons, as inferred by the name, carry sensory information 
from the sensory organs to the brain. Motor neurons control muscle activity, while interneurons 
relay information between peripheral and central neurons. The basic part of a neuron is the cell 
body, axon, and dendrites. Within the cell body, the nucleus controls the cellular activity and 
contains the genetic material. The axon transmits a message, while the dendrites receive 
incoming chemical messages. In terms of stroke, the neurons suffer hypoxia from decreased 
perfusion secondary to diminished glucose and ATP viability (Jakel & Dimou, 2017). 
 Glia. The function of a glial cell is to provide support for the neuron. Upon discovery, 
these cells were named after the belief that they acted as the glue – derived from the Greek word 
glue -- for neurons, essentially holding them together (Jakel & Dimou, 2017). Recent findings 
have shown that there are vital roles that glial cells play in maintaining the neuronal environment 
(Jakel & Dimou, 2017), significantly extending their function in the healthy and injured brain 
beyond that of “glue” and support. Three main types of glial cells are astrocytes, 
oligodendrocytes, and microglia.  
Astrocytes. Functionally, astrocytes maintain, mediate, and restore neuronal function 
during pathologic and physiologic conditions (Morrison & Filosa, 2016). An astrocyte is a highly 
branched glial cell that as a population, occupies a large amount of space within the brain and 
spinal cord. Through the development of branching, astrocyte processes form a scaffold within 
the CNS that provides structural support for neurons and other glial matter. During a traumatic 
event to the brain tissue, astrocytes will also proliferate and migrate to an area of injury and form 
a hypertrophic tissue from their processes that form a scar around the injured tissue, essentially 
barricading it from healthy tissue. Astrocytes also maintain homeostasis of the interstitial fluid 
through the regulation of ion gradients and synaptic maintenance. Lastly, these cells play a vital 
role in neuronal functioning under hypoperfused conditions. By producing lactate in an 
environment depleted of oxygen and glucose, neurons can maintain a level of function that 
enables the production of ATP used by the neuron for energy (Deb, Sharma, & Hassan, 2010). 
This in turn can prevent necrosis of brain tissue.  
Oligodendrocytes. During development, oligodendrocytes develop from the 
subventricular zone of the lateral ventricles for the cerebellum (Jakel & Dimou, 2017). In the 
spinal cord, oligodendrocytes originate from the ventral regions of the neural tube and in the 
optic nerve, they migrate into the nerve from the third ventricle (Jakel & Dimou, 2017). It is the 
oligodendrocyte precursor cells which migrate to their destination where they then differentiate 
into the more mature oligodendrocytes. The proliferation of the oligodendrocyte progenitor cells 
is controlled by the number of growth factors released from neurons and astrocytes such as 
platelet-derived growth factor (PDGF) or fibroblast growth factor (FGF) (Jakel & Dimou, 2017). 
Oligodendrocytes support the axon of the neuron through the production of a lipid substance 
called myelin.  Myelin is wrapped around the axon of a neuron and serves as a layer of insulation 
that allows for the acceleration of electrical impulses up to 200 m/second, thus increasing 
neuronal functioning (Jakel & Dimou, 2017).   
 Microglia. Microglia, the local immune cells in the brain, functionally survey neuronal 
tissue through constant monitoring of the neuronal environment. During early embryogenesis, a 
significant proportion of these cells migrate from the yolk sac and populate in the 
neuroepithelium (Ma, Wang, & Yang, 2017). The primitive function of microglia in early 
development is the phagocytosis of apoptotic neuronal cells, a manifestation of the creation of 
circuitry in the developing CNS (Ma, Wang, & Yang, 2017). However, the primary function of 
microglia in the adult brain is to monitor neurons and the interstitial environment. In the healthy 
adult brain, microglia morphology is termed as ramified, meaning that they have small somas 
and highly branched or arborized processes. This ramified morphology facilitates their continual 
interaction with neurons and glia within their territory. Through alterations in morphology 
known as ramification, microglia can continually interact with neurons and glia within their 
territory with process activity. This morphologic structure distinguishes microglia from other 
systemic immune cells that infiltrate the brain during cerebral events. Microglia are distributed 
through the parenchyma of the brain and can vary in density depending on regional need and 
density of other cell-types (De Biase et al., 2017). This distribution is optimal for immediate 
response during ischemic events in which deramification occurs upon activation of microglia 
causing a proinflammatory cascade and a decreasing number of projections creating an irregular 
appearance (Morrison & Filosa, 2016). This change in morphologic structure then becomes a 
measurable means of microglia activation in response to an acute physical or chemical injury. 
Microglia as a first responder to ischemic stroke. Microglia are the first line of defense 
and after ischemic brain injury. These cells migrate toward the lesion site and exacerbate tissue 
injury by producing inflammatory cytokines and cytotoxic substances; however, microglia also 
contribute to tissue restoration and remodeling by phagocyting debris. Following an ischemic 
event, microglia activation is the first step in the creation of an inflammatory response in the 
brain, followed by the infiltration of immune cells such as neutrophils and macrophages (Ma, 
Wang, & Yang, 2017). Within minutes, activated microglia produce nitric oxide, 
proinflammatory cytokines, anti-inflammatory cytokines, growth factors, and plasminogen (Ma, 
Wang, & Yang, 2017). For example, tumor necrosis factor -alpha is a proinflammatory cytokine 
upregulated after an ischemic stroke that enhances the tolerance of immune cells to withstand 
oxidative stress and ischemic injury but causes an increase in swelling, infarction volume, and 
neurological deficits post-stroke (Perry & Teeling, 2013). This is also seen in proximal and distal 
activation of microglia to the site of infarction. Activated microglia in the infarct zone have a 
negative correlation with tissue preservation, but in the remote area, activated microglia have a 
positive correlation with tissue preservation (Morrison & Filosa, 2016).  
Summary and Study Objectives 
 In summary, strokes can be differentiated into multiple classifications each with specific 
causes that lead to neuronal death and loss of brain function. Glial cells also contribute to brain 
function and are exquisitely linked to neuronal action during health and disease and are therefore 
impacted by interactions with hypo-perfused neurons post-stroke. The objective of this study is 
to investigate changes in microglia morphology after ischemic stroke and 8 hours of reperfusion 
in female (pre-menopause and post-menopause) and male mice. We hypothesize that because the 
size of infarct is decreased in pre-menopause female versus post-menopause female and male 
mice, that changes in microglia morphology post stroke will vary according to sex group. In the 
next chapter, we discuss, in greater detail, the events that occur after ischemic stroke that results 
in brain injury and the influence of biological sex on post-stroke brain injury. 
Chapter 2 
Pathophysiology of Ischemic Stroke 
 As described above, ischemic stroke is a term that depicts conditions in which blood flow 
to the cerebral tissue is impeded resulting in tissue damage and infarction. Ischemic stroke can 
manifest in an embolic stroke, venous thrombosis, thrombotic stroke, or systemic hypoperfusion. 
Beyond cause, the vasculature supply is compromised, and neurons cannot recover from low 
energy reserves and a critical dependence on anaerobic metabolism. These factors put tissue at 
high risk for ischemia under such conditions. This damage occurs on a continuum where necrotic 
tissue correlates to blood flow below <10-25% of normal volume and is proximal to the vessel 
blockage, while the tissue distal to the site of stroke, the penumbra, is an area of hypo-perfused 
but viable tissue at risk for necrosis if ischemia is not resolved (Deb, Sharma, & Hassan, 2010). 
The penumbra is the target of medical and nursing therapeutics to increase blood flow to the 
brain or limit neuroinflammation. During an ischemic event, the inner core is critically hypo-
perfused at less than 10 ml/100 g/min and is at risk of dying, while the penumbra is perfused at 
approximately 60 ml/100 g/min and is less likely to die (Deb, Sharma, & Hassan, 2010). 
Neurons in the penumbra are mostly dysfunctional but may recover if perfused in time. This 
forms the basis of current treatments which favor early pharmacologic intervention for 
reperfusion of tissue.  
Brain damage as a result of ischemia occurs through the ischemia cascade which causes 
local depletion of oxygen and glucose causing decreased production of energy compounds such 
as ATP (Deb, Sharma, & Hassan, 2010). With a loss in energy stores, cellular functioning cannot 
occur which culminates in injury and death. Depending on the cell’s location of ischemia in 
conjunction with the severity and duration of infarction, the damage can be minuet causing 
minimal side effects or drastic which can lead to functional brain loss. Since neurons require 
constant oxygen and glucose, it is susceptible to changes under hypoxic conditions in the case of 
strokes. The changes involved in tissue injury are mitochondrial failure associated with depleted 
energy stores, loss of membrane ion function, excitatory neurotransmitters, production of 
reactive oxygen species, and apoptosis (Patel, 2008).  
In hypoxic conditions, neuronal tissue function can only be sustained for a temporary 
amount of time. When storages of energy are depleted from mitochondrial reserves, the cell can 
be triggered to undergo apoptosis. Ischemia also causes a loss of ATP and potassium, which are 
important for energy exchange across the membrane. Though energy depletion rarely results in 
immediate cellular death, temporary occlusions or partial occlusions for prolonged periods of 
time can result in irreversible brain damage from deterioration of the ion gradients by the by-
products of anaerobic metabolism (Patel, 2018). Under such conditions, potassium is a loss in 
exchange of sodium, chloride, and calcium ions, which in addition to an influx of water, results 
in cytotoxic edema, or rapid swelling of neurons and glia. Ischemia also directly results in 
dysfunction of the vasculature within the brain with a breakdown of the blood-brain barrier 
occurring within 4-6 hours after infarction (Deb, Sharma, & Hassan, 2010). Following the 
barrier’s breakdown, proteins and water flood into the extracellular space, leading to vasogenic 
edema. This produces greater levels of brain swelling and mass effect that peak at 3-5 days and 
resolve over the next several weeks with resorption of water and proteins. 
 During the ischemic cascade, cells release excitatory neurotransmitters such as glutamate 
that are toxic at high concentrations. Glutamate is responsible for sending signals between nerve 
cells, and under optimal conditions, this plays a role in learning and memory; however, during 
hypoxic conditions and ischemic areas, this activates N-methyl-d-aspartate (NMDA), -amino-3-
hydroxy5-methyl-4-propionate (AMPA) which triggers Na+ and Ca2+ influx (Deb, Sharma, & 
Hassan, 2010). As a result, the neuronal membrane utilizes depleting ATP storages to maintain 
calcium balance and has unorganized activation of enzymes within the cell. These enzymes and 
their metabolic products, such as oxygen free radicals, damage cell membranes, genetic material, 
and structural proteins in the neurons, ultimately leads to cell death (Deb, Sharma, & Hassan, 
2010). Though it is known that glutamate is released through these mechanisms, the pathway of 
release during ischemic injury is ambiguous.  The activation of excitatory receptors causes 
neuronal depolarization which further causes the release of glutamate and the influx of calcium 
which activates degradative enzymes and leads to the destruction of cellular membranes and 
other structures (Deb, Sharma, & Hassan, 2010). This ultimately results in glutamate toxicity and 
the consumption of scarce resources.  
 During hypoxic conditions, the byproducts of cellular respiration produce reactive 
oxygen species that damage cellular and extracellular elements, specifically vascular 
endothelium. Through redox signaling, it also initiates apoptotic pathways that induce cellular 
death. In contrast to necrotic causes of cellular death in the ischemic core, apoptosis occurs in the 
peripheral neurons in response to ischemic damage (Deb, Sharma, & Hassan, 2010). This 
ischemic damage triggers Bcl-2 and p53 gene expression, followed by the release of proapoptotic 
molecules such as cytochrome c and apoptosis-inducing factor from the mitochondria (Patel, 
2018).  
 Within hours to days after a stroke, specific genes are activated, leading to the formation 
of cytokines and other factors that, in turn, cause further inflammation. Ultimately and if 
unresolved, the ischemic penumbra is consumed by these factors which result in the death of 
astrocytes, oligodendroglia and microglial cells. The infarcted tissue eventually undergoes 
necrosis and is removed by macrophages, with the development of functional tissue loss in the 
weeks to months following the infarction.  
Pathophysiological Underpinnings of Sex Differences in Ischemic Stroke 
Although lifetime risk of stroke is higher for men than for women, women tend to have 
more severe strokes, more stroke deaths, and increased post-stroke dysfunction compared to men 
(Mozzafarian et al., 2016). From ages 19–30, and again from ages 45 to 54, women have an 
increased stroke risk (Mozzafarian et al., 2016), and one plausible explanation for the increased 
risk of stroke during these time periods is alterations in estrogen status.  
 Role of sex hormones. It is well known that sex-specific hormones play a key role in the 
neuroprotection and neuromodulation of stroke response. Estrogen, progesterone and androgens 
all aid in the stroke response by altering cellular responses via activation and inhibition.   
The role of estrogen. Estrogens are a steroid hormone that regulate female reproductive 
function and act upon the cardiovascular, immune, and central nervous system through binding 
to estrogen receptors. Apart from being highly expressed in reproductive and neuroendocrine 
regions like the hypothalamus, estrogen receptors are widely distributed in the brain. Sex 
hormones modulate not only neuronal function; they exert their actions on different cellular 
targets, modulating an important number of physiological processes. Estrogen impact on stroke 
have been modeled in ovariectomized female mice that allow researchers to remove endogenous 
estrogen and resupply estrogens to evaluate therapeutic potential (Gibson, 2006). Overall, 
estrogens reduced lesion volume in a dose-dependent manner when administered up to a week 
before or up to four hours after transient or permanent cerebral ischemia (Gibson, 2006). The 
three forms of estrogen synthesized by the ovaries are estrone (E1), estradiol (E2), and estriol 
(E3) (Zarate, Stevnsner, & Gredilla, 2017). 17-beta-estradiol (17β-E2), which is involved in 
ischemic injury mediation following stroke, demonstrates the neuroprotective capabilities of 
estrogens through promoting transcription of genes involved in neuronal survival, expression of 
proteins, and the inhibition of neurodestructive factors (Petrone, Simpkins, & Barr, 2014). 
Following focal brain injuries, 17β-E2 administration in mice has shown an increased expression 
of proteins involved in cell survival including phosphoinositide 3-kinase, cyclic-AMP response 
element binding protein, superoxide dismutase, and protein phosphatase 2A (Petrone, Simpkins, 
& Barr, 2014). In addition, 17β-E2 inhibited the expression of pro-apoptotic proteins and 
cytochrome-c release (Petrone, Simpkins, & Barr, 2014).   
Because the immune response following stroke dictates functional recovery and the 
extent of brain damage, 17β-E2 may be dually protective in stroke by also mediating the immune 
response. Following ischemia, there is a rapid local production of estrogen, indicating that the 
hormone may be involved in an immediate physiological response to limit tissue damage 
(Koellhoffer & McCullough, 2014). This early production of estrogen occurs simultaneously 
with the upregulation of innate immune responses. 17β-E2 has been shown to inhibit production 
of neutrophil chemoattractants in the ischemic region, preventing an excessive neutrophil 
response that would increase inflammation (Koellhoffer & McCullough, 2014). This hormone 
also limits the adhesion of neutrophils to endothelial cells on the vasculature which prevents 
excess infiltration from circulating neutrophils (Koellhoffer & McCullough, 2014). 17β-E2 can 
also resolve an inflammatory response by assisting in the clearance of neutrophils from brain 
Koellhoffer & McCullough, 2014) and inducing anti-inflammatory cytokines to limit infarction 
following ischemic stroke (Petrone, Simpkins, & Barr, 2014).  
The role of progesterone. Progesterone is another sex hormone that is characterized by 
reproduction regulation. Progesterone receptors are expressed widely throughout the brain and 
have been described to be present along glial cells (Zarate, Stevnsner, & Gredilla, 2017). Among 
others, progesterone reduces proinflammatory cytokines, modulates neurotransmission, 
suppresses microglial activation, and aids in myelin repair, which suggests that this sex steroid 
has positive effects on outcomes post-stroke (Spychala, Honarpisheh, & McCullough, 2017). 
These neuroprotective effects involve different mechanisms of action, among them, progesterone 
activates the mitogen activated protein kinase (MAPK) and phosphoinositide 3-kinase/ 
serine/threonine kinase (PI3K/Akt) pathways which aid in cellular survival after injury (Zarate, 
Stevnsner, & Gredilla, 2017). However, when delivered in conjunction with estrogen, studies 
have found that progesterone often acts as an antagonist to estrogen within the CNS (Zarate, 
Stevnsner, & Gredilla, 2017). Though the precise mechanism is poorly understood, it is believed 
that the regulation of ER expression is responsible for this antagonistic effect (Zarate, Stevnsner, 
& Gredilla, 2017).  
The role of androgens. Androgens are sex steroid hormones that generally control male 
sex traits and development, but also influence female sexual behavior. Androgens are capable of 
both detrimental and beneficial effects which suggest that maintaining androgen levels within the 
adult ‘normal’ physiological range is likely the optimal condition to minimize risk for stroke. 
Several mechanisms have been identified that demonstrate the neurodestructive abilities of 
androgens; however, exogenous testosterone or steroids use can increase glutamate-induced 
calcium influx, thereby increasing excitotoxic injury in oligodendrocyte and glial cells 
(Quillinan, Deng, Grewal, & Herson, 2014). Moreover, in neuronal cultures using GABA as an 
excitatory neurochemical, testosterone has been shown to increase GABA induced calcium 
influx and injury (Quillinan, Deng, Grewal, & Herson, 2014). This hormone has also been 
observed to induce pro-apoptotic genes and increase injury through increased inflammation and 
altered cell-signaling (Quillinan, Deng, Grewal, & Herson, 2014). However, several studies have 
demonstrated that androgens can be neuroprotective under conditions of glucose deprivation in 
both neurons and astrocytes through increased antioxidant catalase activity, increased expression 
of salt-induced kinase 1, and CREB activation (Quillinan, Deng, Grewal, & Herson, 2014).  
 Role of menopause. While sex hormones as a unit are of importance as a risk factor for 
stroke, it is evident that menopause is attributed to the difference in incidence as evidenced by 
premenopausal women having a much lower incidence compared to young males yet doubling 
that of men at the end of menopause. Menopause is defined as the absence of menstrual periods 
for 12 consecutive months. The menopausal transition, stage of menopause-associated with a 
cessation in reproductive fertility caused by a decrease in hormone production, is associated with 
significant hormonal changes – most importantly, diminished production of estradiol by 60% 
(Lisabeth & Bushnell, 2011). As a consequence, estrogen levels decline steeply after menopause, 
whereas testosterone level remains more or less unchanged, leading to a state of 
relative androgen excess (Lisabeth & Bushnell, 2011). The drop in estrogen places tissue at a 
high risk since the anti-inflammatory properties are no longer at bay. Furthermore, the androgen 
excess is positively correlated with insulin resistance and type-2 diabetes in the elderly 
population which increases the risk for stroke.  
Neuroinflammation after Ischemic Stroke 
 Defining neuroinflammation. Neuroinflammation is the inflammatory response within 
the nervous system. Generally, an inflammatory response occurs as a reaction to foreign invasion 
or injury to the tissue that involves the release of proinflammatory mediators such as chemokines 
and cytokines. When uncontrolled, this inflammatory process can increase tissue damage and 
impair restoration of injury. Neuroinflammation is regulated by the production chemokines, 
cytokines, and reactive oxygen species (Cherry, Olschowka, & O’Banion, 2014). The extent to 
which neuroinflammation is initiated is dependent on scene, duration, and course of insult. This 
inflammatory process can then both serve supportive and destructive functions as part of its 
mediation of injury. The neuroprotective role of neuroinflammation is to increase glial cell 
activation and surveillance. For example, during low transient inflammation, the immune cell 
signals to the brain by increasing the expression of interleukin (IL)-1 cytokine, this then 
increases the surveillance role of glial cells in the brain if infected (Liu et al, 2017). The transient 
inflammation of traumatic CNS injury, following the expression of IL-4, has been shown to 
promote injury recovery and axonal regrowth (Liu et al, 2017). However, the neurodegenerative 
aspects of neuroinflammation increase the production of cytokines (IL-1 and tumor necrosis 
factor), reactive oxygen species (ROS), and other inflammatory mediators including inducible 
nitric oxide synthase (Liu et al, 2017). Following the acute phase of CNS trauma, the IL-1 and 
IL-6 give rise to collateral damage through driving a low-level and chronic inflammatory 
response that to cognitive impairments and reduced neuronal plasticity (Liu et al, 2017). Acute 
inflammation is a defensive response that creates a foundation for tissue repair. Chronic 
inflammation, however, results from consistent stimuli. To identify the principles of general 
neuroinflammation, acute and chronic neuroinflammation will be defined in the context of 
ischemic stroke.  
Acute vs chronic neuroinflammation. Historically, the term “reactive gliosis” was used 
to describe the response of glial cells to CNS tissue injury. Reactive gliosis referred to the 
nonspecific change in glial cells such as proliferation, hypertrophy, or morphology (Streit, Mrak, 
& Griffin, 2004). However, it is now known that glial cells respond through activation into an 
aggressive role rather than the previous notion of passive response. In this activated form, glial 
cells release tissue factors that cause leukocytes infiltration or an increase in rapid activation of 
other glial cells (Streit, Mrak, & Griffin, 2004). This type of inflammation is seen with injury 
rather than a disease which is associated with chronic neuroinflammation. Chronic 
neuroinflammation produces excessive microglial activation in addition to infiltrating leukocytes 
that ultimately translate into a cycle of neurodegeneration (Streit, Mrak, & Griffin, 2004). In 
ischemic stroke, it is considered that the major contributors to ischemic neuronal injury are 
excitotoxicity, oxidative stress, and inflammation (Liu et al, 2017). During the process of 
reperfusion after ischemia, superoxide and nitric oxide produced from damaged cells and 
depletion of glutathione, an antioxidant against ROS occur. This results in acute inflammation 
from dying cells and tissue debris, especially because in ischemic stroke, a blockage prevents 
nutrients from perfusing cells while also inhibiting the removal of waste products.  
 Microglia’s role in neuroinflammatory response to ischemic stroke. It is known that 
during ischemic stroke, neuroinflammation occurs as a result to ischemia-induced cell debris and 
increased ROS which activates microglia and enhances the production of these proinflammatory 
cytokines. During ischemic stroke, microglia transform their morphology from its ramified 
surveillance state to a motile amoeboid state once reperfusion of the brain occurs. These 
activated cells then act as phagocytes and engulf endothelial cells which allow for the entrance of 
blood serum components (Cherry, Olschowka, & O’Banion, 2014). Several studies have 
demonstrated that this early activation of microglia in the neuroinflammatory response increases 
the infarcted area causing cells to undergo apoptosis. Contrary, microglial activation can promote 
active microglia migration to the penumbra in delayed stages of neuroinflammation and assist in 
cell survival (Streit, Mrak, & Griffin, 2004). During activation, microglia morphology is changed 
either to M1, the typically activated phenotype, or to M2, an alternatively activated phenotype, 
after stroke (Cherry, Olschowka, & O’Banion, 2014). M1 microglia activated by LPS and the 
pro-inflammatory cytokine interferon-gamma (IFN-γ) shows harmful effects after stroke (Colton, 
2009). In contrast, M2 phenotype microglia contribute to stroke recovery through anti-
inflammatory cytokines such as IL-4 (Colton, 2009). In ischemic stroke, the M2 phenotype is 
more likely to be induced by ischemic neurons to promote tissue restoration.  
M1 microglial activation. The classical activation of microglia in neuroinflammation is 
the M1 state. This term was originally formulated after the association of IFN-γ produced by Th1 
cells and the importance of it in polarizing microglia (Colton, 2009). It is now known that 
microglia partially control their own activation through autocrine and paracrine means. In many 
cases, this response is neuroprotective, however, chronic activation of these cells can lead to 
tissue damage. In addition, the ratio of cytokines has been used to identify inflammatory 
macrophages and in microglia, IL-12 and IL-10 production are used as a marker for 
distinguishing inflammatory cells Colton, 2009). Another potential distinction and an important 
component of M1 microglia is their ability to produce reactive oxygen species and reactive 
nitrogen species which correlate with an increase in apoptosis (Colton, 2009).  
M2 microglial activation. Inflammation generated by stroke and ischemic reperfusion 
injury is generally considered harmful to the issue as the M1 phenotype is favored; however, M2 
phenotype activation has been shown to downregulate inflammation and initiate cellular repair 
(Cherry, Olschowka, & O’Banion, 2014). This has been demonstrated in mice that lack IL-4 or 
IL-10 which results in an increase in the infarct zone (Cherry, Olschowka, & O’Banion, 2014). 
This response also promotes debris clearance, extracellular matrix deposition, and angiogenesis 
(Cherry, Olschowka, & O’Banion, 2014). Overall, the damage that results from an ischemic 
insult is dependent on the transition from the M1 to M2 phenotype to efficiently restore tissue 
function. However, in cases where the transition is not made and there is a constant activation of 
the M1 phenotype, the continued production of proinflammatory cytokines results in further 
tissue damage and an increase in the infarct zone (Cherry, Olschowka, & O’Banion, 2014).  
Sex Differences in Microglia Function in Response to Stroke 
The sex-differences in microglia abundance and phenotype are prominent in the brain, 
however, it is in the response to stimuli that marks sex-differences in outcomes rather than the 
number of cells. In a study conducted by Villa et al. (2018), microglia cells maintain sex-specific 
expression independent to circulating hormones as evidenced by transplantation of microglia into 
the opposite sex. Through defeminizing the brain using estrogens, the researchers found that the 
expression of certain genes was altered, suggesting that the sex of microglia is determined at 
birth (Villa et al., 2018).  As discussed in chapter 1, perinatal microglia cells migrate to the brain 
in early fetal development and undergo precise temporal phases that characterize microglia 
development and sexual differentiated differences. (Matcovitch-Natan et al., 2016). This sexual 
dimorphism persists in the adult brain through varying amounts and morphology of microglia in 
different anatomical regions (Rahimian, Cordeau, & Kriz, 2018). It is likely that the variances in 
early development lead to divergence in microglia inflammatory responses. Indeed, sex 
differences in microglial activation patterns following brain injuries have been reported by 
different groups. Bodhankar et al. (2015) found that after middle cerebral artery occlusion 
(MCAO), microglia from female mice had a milder inflammatory phenotype compared to males. 
In addition, other experimental stroke models have demonstrated the increase in microglial 
density at the lesion border in male mice (Caplan et al., 2017). Other models showed that 
separated male and female microglia perform differently when exposed to inflammatory triggers 
such as lipopolysaccharides (LPS). Male microglia showed a higher proinflammatory response to 
LPS compared to the female cells, yet the exposure to E2 resulted in an anti-inflammatory effect 
in male neonatal microglia and a proinflammatory effect in female neonatal microglia (Loram et 
al., 2012). Collectively, these observations suggest sex differences in the microglial activation 
patterns following injury and stress. It is possible that the observed sex differences in the 
microglial activation patterns after stroke may trigger distinct downstream signaling cascades 
and thus have a significant impact on the damage associated with ischemic injury.  
While the meaning of this sexual differentiation is unclear, it has been shown that this 
biological event has functional repercussions on the damage caused by MCAO. As mentioned 
previously, males are associated with increased stroke incidence and poorer outcomes are 
attributed to the findings that female microglia are more apt to reduce ischemic damage 
compared to their male counterpart. By analyzing the downstream signaling pathways for 
responses to ischemic damage, the male and female stroke incidence and outcomes can be 
explained.  
One example of the sexual dimorphic responses is caspase-mediated cell death. Female 
microglia primarily follow caspases mediate cell death whereas the caspase-independent Poly 
(ADP-ribose) polymerase-1 (PARP-1) cell death and nitric oxide pathway predominate in males 
(Rahimian, Cordeau, & Kriz, 2018). The loss of either PARP1 or nitric oxide synthase reduces 
infarct volume only in males (Rahimian, Cordeau, & Kriz, 2018). In addition to cell death 
mechanisms, it has been reported that stroke-induced inflammatory and/or anti-inflammatory 
signaling is sexually dimorphic. Examples include peroxisome proliferator-activated receptor 
alpha (PPAR-α), and peroxisome proliferator-activated receptor gamma (PPAR-γ), high mobility 
group box 1, IL-4 receptor and IGF-1 signaling pathways (Rahimian, Cordeau, & Kriz, 2018). 
PPAR- α and PPAR- γ activation primarily affects microglia polarization and inhibition of 
inflammatory signaling cascades through decreasing nuclear translocation of the nuclear factor 
kappa-light-chain-enhancer of activated B cells in neurons in experimental stroke (Dotson et al., 
2016). Treatment with a PPAR- α agonist prior to stroke is only neuroprotective in males, 
probably because of the lower PPAR- α expression in the female brain (Dotson et al., 2016). 
 In addition to cell-death-associated pathways, the sex differences have been also 
reported in the levels of many cytokines and chemokines. Recent evidence suggests that 
neuroprotective cytokines such as IL-4 may stimulate sex-dependent signaling after stroke. 
Xiong et al. (2015) demonstrated that IL-4 is crucial for female neuroprotection after ischemic 
stroke through the stimulation of galectin-3 expression and release. Galectin-3 over-expression is 
a feature of M2 activation that binds to and cross-links to CD98 on macrophages (Xiong et al., 
2015). In addition, IL-4 can initiate the activation of PPAR- γ via IL-4 receptor-dependent 
signaling pathways to provide neuroprotection against inflammation (Rahimian, Cordeau, & 
Kriz, 2018). In a study conducted by Lalancette-Herbert et al. (2012), galectin-3 played an 
instrumental role in microglial activation and proliferation in response to ischemic stroke and in 
male mice, was attributed to an increase in apoptotic neurons and an increase in the infarcted 
tissue. Downstream of galectin-3 is insulin-like growth factor-1 (IGF-1). IGF-1 is a key molecule 
in galectin3-induced microglia proliferation and M2 activation that provides neuroprotection 
through decreasing the size of infarction and provoking neurogenesis (Sohrabji & Williams, 
2013). When galectin-3 is removed, IGF-1 levels are markedly decreased which resulted in 
decreased M2 microglial proliferation and an increase in neuronal damage (Lalancette-Hebert et 
al., 2012). This evidence demonstrates a few of many sex-dependent responses that microglia 
undergo in response to ischemic stroke.  
Summary 
 In summary, the sex-differences in ischemic stroke outcomes are highly connected to the 
sexual dimorphic environment and morphology of microglia which result in dynamically 
different responses to neuronal damage. The roles of sex hormones create the foundation for 
responses through acting as neuroprotective or inflammatory mediators. These then take part in 
the difference in microglial activation pathways and dimorphic functions. By understanding the 
specific pathways that male and female microglia undergo, the more specific stroke therapies can 
be developed to preserve tissue, decrease mortality and reduce disability.  
Chapter 3 
Methods to Study Ischemic Stroke 
Developing effective clinical treatments for ischemic strokes is dependent on 
understanding the pathophysiology of injury. Developing this basis requires the use of animal 
models that mimic human insults so that reliable results can be replicated and restudied for 
further therapeutic modalities. As recommended by the Stroke Treatment Academic Industry 
Roundtable (STAIR), prehospital testing research and treatment management should demonstrate 
evidence of safety in stroke models (Albers et al., 2011). The methods used in this project to 
study ischemic stroke were middle cerebral artery occlusion (MCAO) model. 
 Middle cerebral artery occlusion model. The brain is perfused via the internal carotid 
and vertebral arteries. The MCAO model is formulated around occluding the middle cerebral 
artery which is a distal branch of the internal carotid artery. As the supplier of most of the outer 
brain tissue including the anterior and posterior internal capsules and the basal ganglia, an 
occlusion of this vessel is not only a commonly found cause of human stroke but replicates 
clinical cerebral ischemia (Sutherland, et al., 2017). The middle cerebral artery can be accessed 
internally or externally and can result in temporary or permanent occlusion based on the study 
protocol. The intraluminal filament MCAO stroke model conducted in rats was developed by 
Koizumi in 1986 (Sutherland, et al., 2017). This model uses a temporary insertion of a filament 
through the internal common carotid artery to the ostea of the MCA to occlude the vessel 
resulting in ischemia to the tissue (Sutherland, et al., 2017). For this experiment, the ischemic 
period occurred for a continuous 60-minute period and produced at least a 70% reduction in 
blood flow and reperfusion of at least 70% return of blood flow when compared to the animal’s 
baseline (Morrison & Filosa, 2013). The advantages of this method are eliminating the need for a 
craniotomy, production of a focal occlusion, and standardizing the area of infarct (Shahjouei et 
al., 2016). This procedure can also be reproduced multiple times and result in almost identical 
areas of ischemia which improves standardized outcomes in research.  
 Animals used in ischemic stroke models. There are a variety of animal stroke models 
that have been developed with the goal of identifying the underlying mechanisms behinds 
cerebral ischemia and to develop new therapies for strokes (Fluri, Chuhmann, & Kleinschnitz, 
2015). Most stroke experiments are carried out in small animals such as rabbits, mice, and rats. 
The use of small animals as subjects present clear advantages compared to studying acute strokes 
in humans in the clinical setting. Ischemic strokes in humans are vastly diverse in anatomic 
location, manifestations, and causes, whereas experimental strokes are highly reproducible and 
well-controlled which limit extraneous variables. In addition, the use of animal models allows 
for controlled reperfusion and vasculature which cannot be studied in in-vitro models (Fluri, 
Chuhmann, & Kleinschnitz, 2015). The most common animal subject of ischemic stroke is the 
rodent. Rodents are good subjects as the cerebral vasculature is similar to humans, the small 
body size allows for easy monitoring of hemodynamic parameters, and there is a relative 
homogeneity among strains which can improve the reproducibility of results (Fluri, Chuhmann, 
& Kleinschnitz, 2015).  
 Methods to model female post-menopause. Female C57Bl6/J mice were purchased at 5 
weeks old in order to induce ovarian failure as a model of the human post-menopause period. We 
employed the post-menopause protocol as previously published (Haas, Christian, & Hoyer, 2007; 
Van Kempen et al., 2014). As a brief summary, 5-week-old female mice were injected for 21 
days with 4-vinylcyclohexene diepoxide (VCD, 160 mg/kg/i.p./day). Follicle depletion and 
ovarian cessation was assessed ~65 days after first injection via vaginal lavage, and ovarian 
failure was confirmed by observing 15 days of persistent diestrus prior to tissue collection. At 
this point, 10 weeks after VCD injections and at 16 weeks of age, mice underwent a surgery to 
induce ischemic stroke as described in the section above.  
Animal usage. All animal handling and experiments were performed according to 
methods approved by and in compliance with the University of Arizona Institutional Animal 
Care and Use Committee and according to the National Institutes of Health guide for the care 
and use of laboratory animals (protocol approval number 14-539). All animals were housed in 
rooms with a 12-hr light/dark schedule (7am-7pm). 
Methods to Study Microglia 
 Immunohistochemistry. Immunohistochemistry (IHC) is a microscope-based technique 
aimed at visualizing cellular components in a tissue sample. This technique uses target-protein 
binding within tissue to identify cellular components. For this data analysis, coronal sections of 
brain tissue underwent an immunohistochemistry assay to distinguish microglia from other 
resident brain cells. The classical IHC assay involves detection of epitopes expressed by a single 
protein-target within a tissue sample using an antibody capable of binding to those epitopes with 
high specificity, or selectivity to a specific binding site. After the epitope-antibody binding 
complex, a secondary antibody capable of binding the primary antibody with high specificity is 
added. The secondary antibody is coupled to a reporter molecule and after the antibody-antibody 
binding event, a chemical substrate is added which reacts with the reporter molecule to produce a 
colored precipitate at the site of the whole epitope-antibody complex (Morrison & Filosa, 
2013). This fluorescence created by the antibody-antibody binding complex can be detected 
using a fluorescent microscope to create an image of the selected cell type.  
For this study, brain tissue was then collected from all animals after ischemic stroke and 
8 hours of reperfusion. All animals were sedated with 5% isofluorane delivered via a 20% 
oxygen/80% air mixture and systemically perfused with ice-cold phosphate buffered saline via 
cardiac puncture, after which brain tissue was immediately removed. Brain tissue was fixed for 
24h in a 4% paraformaldehyde solution followed by 72h in a 30% sucrose solution, after which 
the tissue was dried and stored at -80°C until sectioning into coronal sections and use for 
immunohistochemistry techniques. 
All IHC was completed on tissue sectioned into 50µm coronal sections (Leica cryostat) 
and stored at -20°C in a cryoprotectant solution (50% 50mM PBS, 30% ethylene glycol, 20% 
glycerol) until IHC experiments. Our IHC protocol, similar to as previously published (Morrison 
& Filosa, 2013, 2016), results in staining of microglia with anti-IBA1. Free floating brain 
sections were first blocked in 10% horse serum solution (0.01M PBS, 0.05% Triton, and 0.04% 
NaN3) for 1h followed by a 72h incubation with primary antibodies as appropriate: rabbit anti-
iba1 at 1:1000 (Wako, 019-19741). A 4-h incubation of 1:250 secondary primaries (Jackson 
ImmunoResearch Laboratories) followed: donkey anti-rabbit Alexa 488 (711-546-152. All tissue 
was incubated in solutions common to all groups to avoid group/batch differences.  All reactions 
were carried forward at room temperature; washes between incubations were done with 0.01M 
PBS for 15min. Slices were then mounted onto slides using Vectashield (Vector Laboratories, H-
1000). 
Photomicrograph Acquisition and Analysis. Microglia morphology was assessed in 
brain regions in proximity to the ischemic injury after ischemic stroke and 8 hours of 
reperfusion. Imaging was accomplished using a Zeiss 880 NLO [30-µm Z-stack at 1-µm 
intervals, 40X/1.3Na C PL-Apo oil objective, and a 212.6 µm x 212.6µm imaged area (1200 
pixels x 1200 pixels)]. Photomicrographs were stacked and split using ImageJ plugins (National 
Institute of Health, https://imagej.nih.gov/ij/) in order to obtain maximum intensity projections of 
all channels. 
 Skeleton Analysis. A method used to quantify microglia morphology from 
photomicrographs was skeleton analysis. The goal of Skeleton Analysis is first model microglia 
from IBA-1 positive photomicrographs to simple “stick images”. Our first step, then, is to 
convert photomicrographs into skeletonized images as shown in Figure 1. In this process, 
maximum intensity projections are created to visualize microglia processes. Next, a series of 
ImageJ software plugins are used to de-speckle the image (to eliminate single-pixel background 
fluorescence), convert to binary, and then skeletonized images. The AnalyzeSkeleton plugin is 
then applied to skeletonize the image and gather data to identify the number of endpoints per 
frame and process length. The information gathered from skeleton analysis aids in the 
identification of branching complexity and process lengths as a measure of response to injury 
severity. This process has been published in greater detail by (Young & Morrison, 2018). 
 Fractal Analysis.  To help quantify the microscopic details of microglia shapes, and as a 
second method to quantify morphology, fractal analysis can be used and is summarized in Figure 
2. Fractal analysis assesses the scaling of the subject and produces a statistical form of 
complexity called fractal dimension. This number measures scale-invariant detail or complexity 
of the image. For a pattern to have fractal scale-invariant detail means that the pattern repeats 
itself infinitely as the resolution increases (Karperien, Ahammer, & Jelinek, 2013). Box-
counting, a subtype of fractal analysis, is used to quantify both gross and minute nuances of 
morphology that are vital in understanding microscopic details of microglia (Karperien, 
Ahammer, & Jelinek, 2013). Box-counting is a sensitive indicator of microglia structural features 
such as ramification, branching patterns, and membrane details. This proven method has become 
a standard for the characterization of microglial morphology. In a dataset, box-counting fractal 
analysis lays increasingly smaller grids over an image and counts the number of boxes 
containing pixels (Karperien, Ahammer, & Jelinek, 2013). Through calculating the box-counting 
dimension, the value produced represents the average rate of change in detail with a concurrent 
change in magnification of the sample image. 
For this analysis, FracLac for ImageJ was applied to three randomly chosen single cells 
per photomicrograph used in each region. Randomly chosen microglia were first made binary 
through the process described for skeleton analysis via cell isolation. Binary images are then 
converted to outlines using ImageJ and analyzed using FracLac for Image J. A more thorough 
description of this process is provided by (Young & Morrison, 2018). Additional morphology 
parameters were assessed using FracLac for ImageJ: lacunarity, density, span ratio, and 
circularity (Figure 2). A full description of these calculations can be found: 
https://imagej.nih.gov/ij/plugins/fraclac/FLHelp/Introduction.htm. Noting the difference between 
these two methods, skeleton analysis is carried out on the entire photomicrograph and is 
considered “high-throughput”, fractal analysis is carried out on individual cells and is 
correspondingly labor intensive. 
Statistical Analysis 
All data are presented as mean ± standard error of mean (SEM). Sex and region differences were 
determined using a two-way ANOVA test with Bonferroni post-hoc testing. All reported p 
values have been adjusted for multiple comparisons. GraphPad Prism 6 was used for statistical 
analyses. 
Summary 
To summarize, the identification and replication of ischemic stroke in animal models are 
vital to understanding the cellular response to injury and developing clinical treatments specific 
to these pathways. The MCAO model allows for experimental designs to become standardize 
and mimic human pathophysiology. Following the induction of stroke and reperfusion, these 
microglia are studied through the identification of IHC and are further quantified with skeletal 
and fractal analysis. This analysis helps to assess the differences between areas of ischemia to 
monitor microglia response to injury as it pertains to injury proximity and sex.  
Chapter 4 
Study Results 
We quantified microglia morphology after 8-hour ischemia to test if there is a focal and 
sex differences in variance in microglial morphological responses to injury. Microglia are 
dynamic cells and changed microglia morphology may correspond to functional responses. We 
initially quantified the ramified morphology after 8-hour occlusion in male, pre-menopause (Pre 
M), and post-menopause (PM) mice in the necrotic core, proximal, distal, and contralateral 
regions using the skeleton analysis method summarized by Figure 1. Figure 3 summarizes 
findings on the ramified morphology among male, Pre M, and PM female mice. Cell 
ramification was operationalized using two variables: endpoints per cell and process length per 
cell. Endpoints/cell and process length/cell data are summarized in Figure 3A and 3B. We show 
that ramified morphology is decreased when in proximity to injury as determined by two-way 
ANOVA analyses (endpoints/cell region main effect:  F(3,68) = 20.71, p < 0.0001; process 
length/cell region main effect: F(3,68) = 11.63, p < 0.0001). These data indicate that microglial 
branching complexity is greater in areas that are not affected by ischemic injury and indicative 
that morphology and proximity to injury are interdependent after ischemic stroke and 8 hours of 
reperfusion. However there were no differences among sex groups for the endpoints/cell variable 
(two-way ANOVA sex main effect: F(2,68) = 0.6, p < 0.55) whereas significant sex group 
differences for the process length/cell variable (two-way ANOVA sex main effect: F(2,66) = 4.65, 
p < 0.05. In particular, process length/cell was increased in the Pre M group at the proximal to 
injury region when compared to the matching region in the male sex group (Bonferroni post-hoc 
comparison p < 0.05)  In summary, microglia are de-ramified in relation to the focal injury with 
little influence of sex group to modulate these findings.  
 Next, using fractal analysis, we examined the complexity and shape of microglia to 
measure the degree of variance between region and sex group. As previously described and 
illustrated in Figure 2, FracLac for ImageJ was used to outline microglia and quantify fractal 
dimension, lacunarity, density, span ratio, and circularity; these data are summarized by Figure 4. 
In Figure 4A we show that, similar to ramification measures, fractal dimension decreases in 
proximity to the ischemic region with significant differences according to sex group (two-way 
ANOVA: region: F(3,57) = 36.80, p < 0.0001; sex group: F(2,19) = 7.5, p < 0.01). Specific sex 
group differences were noted in the PM and Pre M group versus male when comparing either the 
proximal to injury or adjacent to injury regions. While cell lacunarity (Figure 4B, shape 
heterogeneity) was largely unchanged according to region (F(3,57) = 1.68, p > 0.05) sex group 
differences were present (F(2,19) = 13.80, p < 0.001). Cell density (Figure 4C, cell size) was 
decreased in proximity to the ischemic stroke (F(3,57) = 21.63, p < 0.0001) but without sex group 
differences. Analysis illustrate that no differences were noted for span ratio for either effect, 
region or sex group (two-way ANOVA: region F(3,57) = 2.9, p < 0.05; sex group F(2,19) = 0.3, p > 
0.05). Lastly, microglia circularity was different according to region (two-way ANOVA; region 
F(3,57) = 3.39, p < 0.05) but without sex differences (F(2,19) = 2.93, p > 0.05). In all cases, no 
significant interaction effect was present between region and sex; specific Bonferroni post-hoc 
comparisons are noted in Figure 4.  
Chapter 5 
Discussion 
               As a leading cause of mortality and disability in the United States, ischemic stroke has 
significant clinical impact. As a first responder to neuronal injury, microglia response is a 
variable factor to study. Microglia, as an inflammatory mediator and phagocyte in response to 
ischemic stroke, can improve outcomes or cause trauma. This study tested the hypothesis that 
ischemia would elicit a morphological response to ischemic stroke injury hours after reperfusion 
and that this morphological response would be different among sex groups: male, premenopausal 
and post-menopausal females. It is imperative to understand the sex-specific variability of 
microglia responses post-injury because the existence of such differences would impact future 
stroke therapies. We assessed microglia morphology 8 hours after reperfusion at four locations in 
the brain in respect to the area of injury among three sex groups (male, pre-menopausal females, 
and post-menopausal females). Through skeleton analysis, a method that uses hyper- and de-
ramification of microglial cells as an indicator of activation (Morrison & Filosa, 2013), we 
illustrate that after 8 hours of reperfusion, microglia expressed an increase in de-ramification in 
proximity to injury. However, there were no significant differences among sex groups after 8 
hours of reperfusion. 
            Microglia cells have an immediate response to injury (Davalos et al., 2005; Morrison & 
Filosa, 2013; Nimmerjahn, Kirchhoff, & Helmchen, 2005). Microglia tend to retract their 
branches after ischemia, leading to a reduction in the total length and the total number of 
microglial processes (Zhang, 2019). In this study, we have confirmed previous work showing 
that microglia morphologic responses are quantifiable and decreased hours after ischemic and 
from reperfusion (Morrison & Filosa, 2013). However, there were no differences according to 
sex group. This finding was different than previous investigations that occurred at an earlier 
time-point—immediately after ischemic stroke (Morrison & Filosa, 2016). We had expected a 
difference between sex groups as there is a clear distinction in clinical outcomes among male and 
female stroke victims. We postulated that sex differences in microglia morphologic responses to 
ischemic injury at this early time-point post stroke may exist, indicative of a functional response, 
and therefore may be a source of variability contributing to sex differences in stroke injury. In 
our ongoing work, and data not presented here, preliminary results from 24-hour reperfusion 
time-point is similar to our findings shown here—a similarity in morphologic responses to injury 
among sex groups. As this is one of the few studies measuring sex differences in microglial 
morphology in response to ischemic stroke, further investigation is warranted to confirm the 
findings of this study. Moreover, coupling the study of morphology and function, while difficult, 
would be informative. 
            In this study, we present data investigating sex differences in microglia morphology as a 
measurable response to ischemic stroke and reperfusion. These findings are vital contributions 
towards understanding sex as a biological variable in science and medicine. A limitation of this 
study included small sample sizes which impact the ability to identify significant relationships 
among the sex groups. It is possible that a larger and more equal sample size could produce a sex           
difference that is clinically significant in terms of morphological response. The skeletal analysis 
protocol poses a potential bias. To avoid bias, all skeleton analysis is carried out by one 
individual blinded to experimental group, when possible. The skeleton and fractal analysis were 
carried out on a two-dimensional projection of microscopic images and as such could lead to a 
substantial loss of end points and ramification that may be present in three-dimensional cell 
shapes (Heidl et al., 2018). The fractal analysis was time consuming and is less efficient for a 
large number of cellular analysis and this limitation could affect a reproduction of this study.  In 
addition, this cross-sectional descriptive study with data collection analysis a single-time point of 
the very dynamic process of phagocytosis which could be a misrepresentation of microglial 
response at a different point in time. Further research should be conducted to compile sex group 
data at 24 hours of reperfusion.  
Clinical Significance 
              In this study, we present a quantitative analysis of the sex differences in microglia 
morphology as a measure of microglia activation after ischemic injury. These findings are vital 
contributions towards understanding sex as a biological variable in science and medicine. As we 
continue to explore the reason behind dichotomous stroke outcomes between the sexes, we move 
closer towards the development of sex-specific stroke therapies (Morrison & Filosa, 2016). The 
closer to understanding and defining the morphological response cells have during ischemic 
injury, the greater are ability to understand their functional response to pathologic conditions 
becomes. The focus of this study is on the basic discovery of microglia morphological response 
that can be used to develop treatments that have minimal side effects and variability among sex 
groups. In this study it was also found that there is hyper- and de-ramification present in respect 
to the site of injury. This is significant as microglia-mediated response can be both 
neuroprotective and neurotoxic depending on the proximity to the area of injury and the presence 
of ramification vs de-ramification—a morphology that may be related to their function. A better 
understanding of microglial actions during stroke pathology will broaden our understanding of 
post-stroke neuroinflammation—a targetable stroke therapy  
              In this study, we focused on target discovery and validation for novel therapeutics to 
better balance microglia mediated post stroke neuroinflammation. To do that, it is imperative to 
develop extensive knowledge on microglia action during stroke physiology in both males and 
females. Although it is valuable to have both male and female sex group, we must distinguish 
and acknowledge the role that hormones play in cellular response (Eldahshan, Fagan, & Ergul, 
2017). Sex as a biological variable should be a factor in biomedical research as experimental 
results obtained from unisex studies may be inadvertently extrapolated. Though there has been 
an increase in sexual equality in clinical trials and studies, there is a lack of analysis to determine 
sex differences in outcomes (Lee, 2018). When experimental conditions are reported clearly, 
both positive and negative data correlations between sex groups are valuable. In relation to this 
study, the finding of no sex differences is significant as alterations in microglial morphology 
could be a potential target for therapies as on a cellular level, the cells remain unchanged. 
However, the dichotomy in sex-specific stroke outcomes still poses a question as it remains 
unknown how biological sex plays a role in the response ischemic stroke. 
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Figure 1 
 
 
 
Figure 1. Typical photomicrograph of microglia immunohistochemistry (IHC; in green) and the 
skeleton analysis method to quantify microglia morphology in histological sections. Briefly, entire 
images were subjected to a series of ImageJ plugins to create a skeletonized model of all microglia 
in the frame (Young & Morrison, 2018). The cropped single cell shows the detail to visualize the 
analysis technique. Once skeletonized, the Analyze-Skeleton plugin tags skeleton elements, in the 
entire photomicrograph, as endpoints (blue), processes (orange), or junctions (purple)(Arganda-
Carreras, Fernandez-Gonzalez, Munoz-Barrutia, & Ortiz-De-Solorzano, 2010). The number of 
endpoints/cell and process length/cell are summarized from data output to quantify microglia 
ramification.  
 
 
 
  
Figure 2 
 
 
 
Figure 2. FracLac for ImageJ(Karperien, 1999-2013) was used to collect morphometrics such as 
fractal dimension, density, circularity, span ratio, and lacunarity. Single microglia are isolated from 
the entire photomicrograph and outlined using ImageJ plugins. Fractal dimension (3.1) is a 
measure of shape complexity and is calculated by FracLac for ImageJ algorithms using the number 
of boxes containing outlined pixels as the box size decreases. Larger fractal dimension values are 
indicative of increased shape complexity. Density (3.2), an indicator of cell size or solidity, is 
calculated by dividing the number of pixels in a cell shape by the area the cell occupies (convex 
hull area, blue). Circularity is an indicator of cell roundness (3.3), whereas span ratio is an indicator 
of shape elongation (3.4). Lacunarity (3.5) measures shape heterogeneity and the variability in 
how a cell shape occupies space. A high lacunarity value indicates that the different parts of a 
cell’s shape are not symmetrical.  
 
  
Figure 3 
 
Figure 3. Microglia ramified morphology is decreased in proximity to brain injury after ischemic 
stroke in male, pre-menopause (Pre M) and post-menopause (PM) female mice. A) Summary 
data (mean and SEM) and statistical analysis (two-way ANOVA) of microglia endpoints/cell in 
brain regions following ischemic stroke and 8hr of recovery. The number of microglia 
endpoints/cell is different than the contralateral hemisphere (F(3,68) = 20.71, p < 0.0001) with 
Bonferroni post-hoc comparisons reported in the figure (# p < 0.05). There are no differences in 
the number of endpoints/cell (F(2,68) = 0.6, p < 0.55) among sex groups. B) Summary data (mean 
and SEM) and statistical analysis (two-way ANOVA) of microglia process length/cell in brain 
regions following ischemic stroke and 8hr of recovery. The microglia process length/cell is 
different than the contralateral hemisphere (F(3,68) = 11.63, p < 0.0001) with Bonferroni post-hoc 
comparisons reported in the figure (# p < 0.05). In one region (proximal to injury), microglia 
process length/cell was different among sex groups (F(2,66) = 4.65, p < 0.05) with Bonferroni 
post-hoc comparisons reported in the figure (* p < 0.05). Sample size: Male n = 5-6; PM n = 8; 
Pre M n = 6 
Figure 4 
 
 
 
Figure 4. Microglia shapes are changed proximity to brain injury after ischemic stroke in male, 
pre-menopause (Pre M) and post-menopause (PM) female mice. A) Summary data (mean and 
SEM) and statistical analysis (two-way ANOVA) of microglia fractal dimension in brain regions 
following ischemic stroke and 8hr of recovery. Microglia fractal dimension is decreased versus 
the contralateral hemisphere (F(3,57) = 36.80, p < 0.0001) with Bonferroni post-hoc comparisons 
reported in the figure (# p < 0.05). Fractal dimension is also different according to sex group 
(F(2,19) = 7.5, p < 0.01) with Bonferroni post-hoc comparisons reported in the figure (* p < 0.05). 
B) Summary data (mean and SEM) and statistical analysis (two-way ANOVA) of microglia 
lacunarity in brain regions following ischemic stroke and 8hr of recovery. Microglia Lacunarity 
is unchanged versus the contralateral hemisphere (F(3,57) = 1.68, p > 0.05; # p < 0.05 vs 
contralateral) but with differences among sex groups (F(2,19) = 13.80, p < 0.001) and significant 
interaction (F(6,57) = 3.62, p > 0.01) with Bonferroni post-hoc comparisons reported in the figure 
(* p < 0.05). C) Summary data (mean and SEM) and statistical analysis (two-way ANOVA) of 
microglia density following ischemic stroke and 8hr of recovery. Microglia density is different 
than the contralateral hemisphere (F(3,57) = 21.63, p < 0.0001) with Bonferroni post-hoc 
comparisons reported in the figure (# p < 0.05) but without differences among sex groups (F(2,19) 
= 2.39, p > 0.05) or interaction (F(3,57) = 3.62, p > 0.05). D) Summary data (mean and SEM) and 
statistical analysis (two-way ANOVA) of microglia span ratio following ischemic stroke and 8hr 
of recovery. Microglia span ratio is different than the contralateral hemisphere (F(3,57) = 2.9, p < 
0.05) but without significant Bonferroni post-hoc comparisons, differences among sex groups 
(F(2,19) = 0.3, p > 0.05) or interaction (F(3,57) = 1.37, p > 0.05). E) Summary data (mean and SEM) 
and statistical analysis (two-way ANOVA) of microglia circularity following ischemic stroke 
and 8hr of recovery. Microglia circularity is different than the contralateral hemisphere (F(3,57) = 
3.39, p < 0.05) with Bonferroni post-hoc comparisons reported in the figure (# p < 0.05) but 
without differences among sex groups (F(2,19) = 2.93, p > 0.05) or interaction (F(3,57) = 0.92, p > 
0.05). Sample size: Male n = 7; PM n = 8; Pre M n = 7 
 
 
 
